Organogenesis sets May 7 date for first-quarter 2026 financial results
Organogenesis Holdings said first-quarter fiscal 2026 financial results will be reported after the market closes on May 7, followed by a 5:00 p.m. Eastern Time conference call.
Organogenesis Holdings Inc. said first quarter of fiscal year 2026 financial results will be reported after the market closes on Thursday, May 7th. Management will host a conference call at 5:00 p.m. Eastern Time on May 7th to discuss the results of the quarter, and to provide a corporate update with a question and answer session.
The live webcast can be accessed via the company’s website at investors.organogenesis.com, and the webcast will be archived on the company website for approximately one year.
The company previously said fourth quarter and fiscal year 2025 financial results would be reported after the market closes on Thursday, February 26th. Management said it would host a conference call at 5:00 p.m. Eastern Time on February 26th to discuss the results of the quarter and the fiscal year, and to provide a corporate update with a question and answer session.
Organogenesis Holdings Inc. is focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets.